FDA Inspection
Teva Pharmaceuticals USA, IncTeva Pharmaceuticals USA, Inc – FDA Inspection, Sep 9, 2025
Record Details
This FDA Inspection record concerns Teva Pharmaceuticals USA, Inc, with an inspection on September 9, 2025, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · b27fe91e-35d8-4c36-b850-89392d7edf51
Inspection Facts
- Inspection number
- 1258587
- FDA center
- Human Drugs
Other FDA inspections of Teva Pharmaceuticals USA, Inc
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 29, 2023 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 16, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 2, 2010 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| March 1, 2010 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 14, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Teva Pharmaceuticals USA, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.